Fresenius Medical Care AG (NYSE:FMS) Q3 2024 Earnings Conference Call November 5, 2024 8:00 AM ET
Company Participants
Dominik Heger – Head, Investor Relations
Helen Giza – Chief Executive Officer and Chair
Martin Fischer – Chief Financial Officer
Conference Call Participants
Richard Felton – Goldman Sachs
Victoria Lambert – Berenberg
Robert Davies – Morgan Stanley
Hugo Solvet – BNP Paribas
Oliver Metzger – ODDO BHF Bank
Sezgi Oezener – HSBC
Giang Nguyen – Citigroup
David Adlington – JPMorgan
Marianne Bulot – Bank of America
Falko Friedrichs – Deutsche Bank
Christian Ehmann – Warburg Research
Operator
Ladies and gentlemen, welcome to the report of the Third Quarter 2024 of Fresenius Medical Care Conference Call. I’m Sandra, the Chorus Call operator. I’d like to remind you that all participants will be in listen-only mode and the conference is being recorded. A replay will be available on the company’s website. The presentation will be followed by a Q&A session. [Operator Instructions] The conference must not be recorded for publication or broadcast.
At this time, it’s my pleasure to hand over to Dominik Heger, Head of Investor Relations. Please go ahead.
Dominik Heger
Thank you, Sandra. I would like to welcome everyone to our earnings call for the third quarter of 2024. Thank you for joining us today. I’ll start by mentioning our cautionary language that is in our safe harbor statement, as well as in our presentation and in all the materials that we have distributed earlier today. For further details concerning risks and uncertainties, please refer to these documents as well as to our SEC filings.
The call is scheduled for 60 minutes. We have prepared a presentation and we’ll have time for your questions after the prepared remarks. We would like to limit the number of questions to two in order to give
Read the full article here
